Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Immunoglobulin G × Sarcoma × Clear all

Phase

Status

Completed 7 Active not recruiting 4 Recruiting 3 Withdrawn 2 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 8 Genitourinary 6 Lymphoid 4 Head & Neck 3 Gynecologic 3 Gastrointestinal 3 Breast 3 Other hematologic neoplasm 2 Sarcoma 1 Plasma cell 1 Myeloid 1 Dermatologic 1 Classical hematology 1 CNS 1

Conditions

Gastrointestinal Stromal Tumors 1

Interventions

Cyclophosphamide 25 Temozolomide 23 Doxorubicin 22 Radiotherapy 21 Filgrastim 19 Ifosfamide 15 Etoposide 13 pazopanib 12 Gemcitabine 12 Cisplatin 12 Irinotecan 11 Imatinib Mesylate 11 Granulocyte Colony-Stimulating Factor 11 Carboplatin 11 Bevacizumab 11 Radiation 9 Magnetic Resonance Spectroscopy 9 fludarabine phosphate 8 Rituximab 8 Methotrexate 8 Docetaxel 8 Cyclosporine 8 Busulfan 8 Antilymphocyte Serum 8 pembrolizumab 7 fludarabine 7 Vincristine 7 Radiotherapy, Intensity-Modulated 7 Mycophenolic Acid 7 Melphalan 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00324987 2017-09-14

S0502

National Cancer Institute (NCI)

Phase 3 Terminated

12 enrolled 13 charts

GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡